K.J. Harrison & Partners Inc - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.

Quarter-by-quarter ownership
K.J. Harrison & Partners Inc ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$216,891
-72.4%
34,640
-67.3%
0.04%
-75.5%
Q1 2023$785,124
-68.9%
105,933
-75.2%
0.16%
-67.7%
Q4 2022$2,522,740
-8.2%
427,583
-10.9%
0.49%
-49.3%
Q3 2022$2,748,000
-70.1%
479,838
-70.1%
0.97%
-60.8%
Q2 2022$9,188,000
-33.2%
1,607,027
+18.9%
2.48%
+12.3%
Q1 2022$13,749,0001,351,7822.21%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders